The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/appi.ps.53.10.1322

The call for formal capacity assessments of potential research participants with impairments due to illnesses such as Alzheimer's disease is increasing. Because such an evaluation of every potential subject requires significant resources, clinicians and researchers may want to know the utility and the limits of a familiar cognitive screening test, the Mini Mental State Examination (MMSE), in capacity evaluations. In this study of 37 patients with mild to moderate Alzheimer's disease, a fairly wide range of MMSE scores (21 to 25, which includes an often used cutoff for "normal") did not discriminate capacity status well. Nevertheless, there may still be approaches that enhance the practical utility of the MMSE in capacity assessment.